Transitional cell carcinoma historical perspective

Jump to navigation Jump to search

Transitional cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transitional cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Cystoscopy and Bladder Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transitional cell carcinoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transitional cell carcinoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transitional cell carcinoma historical perspective

CDC on Transitional cell carcinoma historical perspective

Transitional cell carcinoma historical perspective in the news

Blogs on Transitional cell carcinoma historical perspective

Directions to Hospitals Treating Transitional cell carcinoma

Risk calculators and risk factors for Transitional cell carcinoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

Historical Perspective

Historical staging of transitional cell carcinoma

  • In 1922, Broders et al introduced a grading system based on the portion of undifferentiated urothelial cells.the system observed both bladder urothelium changes over time and prognosis.[1]
  • In 1931, Aschner classified tumors of the bladder as papillary vs solid. by adding up to invasion existence, he found that disease prognosis is poor with solid tumors.[2]
  • In 1944, Jewett and Strong proved a relation between depth of penetration (stage) to the incidence of local extension and metastases.[3]
  • In 1948, McDonald and Thompson proved that there is a co-relation between vascular and lymphatic invasion.they also figured a direct relation between these findings and prognosis.[4]
  • In 1952, Jewett-Marshall-Strong redefined the staging system,to be based on bimanual palpation and biopsy into sub-stages: 0, A and B1 and B2 and C (2).
  • Continuing his studies in 1956 Marshall established gradation of tumor and its staging.[5]

Landmark Events in the Development of Treatment Strategies

Impact on Cultural History

Famous Cases

The following are a few famous cases of [disease name]:

References

  1. Macvicar, A.D. (2002). "Bladder cancer staging". BJU International. 86: 111–122. doi:10.1046/j.1464-410X.2000.00589.x. ISSN 1464-4096.
  2. Kretschmer, Herman L. (1924). "Primary Carcinoma of the Ureter". Journal of Urology. 11 (6): 573–580. doi:10.1016/S0022-5347(17)73709-3. ISSN 0022-5347.
  3. Gospodarowicz, Mary K.; Hawkins, N.V.; Rawlings, G.A.; Connolly, J.G.; Jewett, M.A.S.; Thomas, G.M.; Herman, J.G.; Garrett, P.G.; Chua, T.; Duncan, W.; Buckspan, M.; Sugar, L.; Rider, W.D. (1989). "Radical Radiotherapy for Muscle Invasive Transitional Cell Carcinoma of the Bladder: Failure Analysis". Journal of Urology. 142 (6): 1448–1453. doi:10.1016/S0022-5347(17)39122-X. ISSN 0022-5347.
  4. Dimmette, Comdr. Robert M.; Sproat, Major Harry F.; Sayegh, Emile S. (1956). "The Classification of Carcinoma of the Urinary Bladder Associated with Schistosomiasis and Metaplasia". Journal of Urology. 75 (4): 680–686. doi:10.1016/S0022-5347(17)66863-0. ISSN 0022-5347.
  5. Leder, R A; Dunnick, N R (1990). "Transitional cell carcinoma of the pelvicalices and ureter". American Journal of Roentgenology. 155 (4): 713–722. doi:10.2214/ajr.155.4.2119098. ISSN 0361-803X.

Template:WH Template:WS